Investigation of efficacy and safety of panitumumab in combination with irinotecan/5-fluorouracil/leucovorin (FOLFIRI) in patients with colorectal cancer liver metastasis

ABSTRACT: Primary objectives: Evaluation of efficacy and safety of perioperative treatment including panitumumab and FOLFIRI as first line therapy for mCRC in subjects with potentially resectable liver metastases expressing wild-type RAS Primary endpoints: objective response rate (ORR)

DISEASE(S): Previously Untreated, Wild-type Ras, Potentially Resectable Colorectal Cancer Liver Metastases

PROVIDER: 2530525 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR